![Mark de Souza](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Mark de Souza first degree
Entity | Entity type | Industry | |
---|---|---|---|
NFlection Therapeutics, Inc.
![]() NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.
4
| Holding Company | Biotechnology | 4 |
Phoenicis Therapeutics, Inc.
![]() Phoenicis Therapeutics, Inc. BiotechnologyHealth Technology Phoenicis Therapeutics, Inc. is a private company that is focused on developing therapies for rare dermatological disorders. The company is based in Hingham, MA. The company's goal is to improve the lives of those who suffer from these conditions. The CEO of the company is Deborah Ramsdell.
4
| Private Company | Biotechnology | 4 |
SonALAsense, Inc.
![]() SonALAsense, Inc. BiotechnologyHealth Technology SonALAsense, Inc. provides ALA Sonodynamic Therapy for the treatment of Glioblastoma Multiforme. The company was founded by Stuart Marcus and is headquartered in Berkeley, CA.
3
| Holding Company | Biotechnology | 3 |
SeylanMED LLC
![]() SeylanMED LLC Miscellaneous Commercial ServicesCommercial Services SeylanMED LLC operates as a private biopharmaceutical company that develops a targeted therapy for Seborrheic Keratosis. The company as founded by Victor Neel and Anna Mandinova and is headquartered in Berkeley, CA.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Chromaderm, Inc.
![]() Chromaderm, Inc. BiotechnologyHealth Technology Chromaderm, Inc. operates as a clinical stage biotech company. It develops topical PKC-beta inhibitor. The company was founded by Barbara A. Gilchrest, Mark de Souza and James W. Fordyce and is headquartered in Cambridge, MA.
1
| Subsidiary | Biotechnology | 1 |
FIBRX Derm, Inc.
![]() FIBRX Derm, Inc. Pharmaceuticals: MajorHealth Technology FIBRX Derm, Inc. develops anti-scarring therapeutic for patients with Dystrophic Epidermolysis Bullosa. The company was founded by Mark de Souza, James W. Fordyce and Erkki Ruoslahti and is headquartered in Berkeley, CA.
1
| Private Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark de Souza via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
FIBROGEN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
SeylanMED, Inc.
![]() SeylanMED, Inc. BiotechnologyHealth Technology SeylanMED, Inc. engages in the development of topical akt inhibitor as a treatment for seborrheic keratosis. The company was founded by Victor Neel and Anna Mandinova and is headquartered in Berkeley, CA. | Biotechnology | Founder Founder | |
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
Valerion Therapeutics LLC
![]() Valerion Therapeutics LLC Medical SpecialtiesHealth Technology Valerion Therapeutics LLC develops targeted therapies for orphan genetic diseases. The firm utilizes a proprietary antibody-mediated delivery platform to target therapies to specific tissues via a studied transport pathway. It therapies are based on an intracellular delivery technology platform that takes advantage of tissue targeting via an antibody and intracellular delivery dependent on membrane expression of a nucleoside transporter. The company was founded by Timothy S. Harris and Dustin D. Armstrong in 2007 and is headquartered in Concord, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
DYAX CORP. | Pharmaceuticals: Major | Director/Board Member | |
Orphan Technologies Ltd.
![]() Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Brown University | College/University | Undergraduate Degree | |
Virus Research Institute, Inc.
![]() Virus Research Institute, Inc. BiotechnologyHealth Technology Part of Celldex Therapeutics, Inc., Virus Research Institute, Inc. develops systems for the delivery of vaccines. The company is based in Cambridge, MA. | Biotechnology | General Counsel | |
IMMUNOGEN, INC. | Biotechnology | General Counsel | |
Biotechnica International, Inc.
![]() Biotechnica International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Groupe Limagrain Holding SA, Biotechnica International, Inc. is a company that specializes in agricultural research. The company is based in Shawnee Mission, KS. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Boston College | College/University | Graduate Degree | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Alopexx Enterprises LLC
![]() Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Biotechnology | General Counsel | |
University of California, Berkeley | College/University | Doctorate Degree | |
Lazard Asset Management LLC
![]() Lazard Asset Management LLC Investment ManagersFinance Lazard Asset Management LLC (LAM) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1970 and is a wholly-owned subsidiary of Lazard Frères & Co. LLC, ultimately held by Lazard, Inc. (NYSE: LAZ). LAM manages investment portfolios and provides investment advice to institutional and individual investors around the world. | Investment Managers | Corporate Officer/Principal | |
PellePharm, Inc.
![]() PellePharm, Inc. BiotechnologyHealth Technology PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. The firm also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Michael Henderson, Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA. | Biotechnology | Chief Operating Officer | |
SHIRE | Pharmaceuticals: Major | General Counsel | |
Caregiver Action Network | Director/Board Member | ||
NF2 Therapeutics, Inc.
![]() NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
3CC Management LLC
![]() 3CC Management LLC Investment ManagersFinance 3CC Management LLC (Third Culture Capital) is a venture capital firm founded in 2020 by Julien L. Pham. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Harvard Medical School | College/University | Graduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Yale University | College/University | Undergraduate Degree | |
EB Research Partnership, Inc.
![]() EB Research Partnership, Inc. Miscellaneous Commercial ServicesCommercial Services EB Research Partnership operates as a foundation for the research and treatment of Epidermolysis Bullosa. The company was founded by Alexander Silver, Jill Vedder, Ryan Fullmer, Jamie Silver and Heather Fullmer and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Executive Officer | |
Soros Fund Management LLC
![]() Soros Fund Management LLC Investment ManagersFinance Soros Fund Management LLC (SFM) is a privately-held investment management firm now structured as a family office, but which was once a hedge fund manager. The firm was founded in 1969 and is headquartered in New York City. SFM serves as the principal asset manager for the Open Society Foundations (Open Society) – a private funder of independent groups that works for justice, democratic governance, and human rights. | Investment Managers | Corporate Officer/Principal | |
REPLIGEN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Albert & Mary Lasker Foundation | Director/Board Member | ||
MEDNA Partners LLC
![]() MEDNA Partners LLC Investment ManagersFinance MEDNA Partners LLC private advisory firm. The company is headquartered in Cambridge, MA. | Investment Managers | Corporate Officer/Principal | |
Darwin Ventures LLC
![]() Darwin Ventures LLC Investment ManagersFinance Darwin Ventures LLC (Darwin Ventures) is a venture capital founded in 2002 by Peter Freudenthal and Frank R. Caufield. The firm is headquartered in Burlingame, California. | Investment Managers | Corporate Officer/Principal | |
Critical Biologics Corp.
![]() Critical Biologics Corp. Medical SpecialtiesHealth Technology Critical Biologics Corp. develops and commercializes diagnostics and therapeutics drugs. The firm focuses in the development of a theranostic platform to screen and treat both acute and chronic patients with low plasma gelsolin levels (hypogelsolinemia) at high risk of life-threatening complications. The company was founded by James W. Fordyce, Terence S. Russell, Shun Lee Po, and Thomas P. Stossel in 2006 and is headquartered in Cambridge, MA. | Medical Specialties | Founder | |
Magdalen College School Oxford Ltd | College/University | Undergraduate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin | |
ORE HOLDINGS INC | Financial Conglomerates | Director/Board Member | |
Lotus Tissue Repair, Inc.
![]() Lotus Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Lotus Tissue Repair, Inc. develops dermatologic treatment technologies. Its solutions include a protein replacement therapy for the treatment of dystrophic epidermolysis bullosa, a group of genetic skin disease. The company was founded by Mei Chen, Mark P. de Souza, Philip R. Reilly, David Woodley and James W. Fordyce in 2011 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Founder | |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
VelQuest Corp.
![]() VelQuest Corp. Packaged SoftwareTechnology Services VelQuest Corp. provides integrated compliance management solutions. The company's software is used by pharmaceutical companies to reduce compliance risk, liberate valuable resources and add value to existing document management and IT resources. Its SmartLab GMP Electronic Notebook System is built on electronic process management and compliance core operating system to provide the foundation for compliance based activities in the life science markets. The firm's services include planning and consulting, implementation, validation, customer education, field Service and customer support. VelQuest was founded in January, 1999 and is headquartered in San Diego, CA. | Packaged Software | Director/Board Member | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
DUSA Pharmaceuticals, Inc.
![]() DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
DaIIchi Pharma Holdings, Inc. | Corporate Officer/Principal | ||
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal | |
Oakland University (Michigan) | College/University | Undergraduate Degree |
Statistics
International
United States | 47 |
Canada | 2 |
Switzerland | 2 |
Ireland | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 24 |
Consumer Services | 12 |
Finance | 9 |
Commercial Services | 4 |
Technology Services | 2 |
Operational
Director/Board Member | 22 |
Corporate Officer/Principal | 14 |
Founder | 13 |
Chief Tech/Sci/R&D Officer | 10 |
Chief Executive Officer | 9 |
Most connected contacts
Insiders | |
---|---|
James Fordyce | 14 |
Deborah Ramsdell | 11 |
William Hodder | 9 |
Hal Landy | 7 |
Alex J. Silver | 7 |
Gerd Kochendoerfer | 6 |
Kenneth Tsai | 6 |
Joff Masukawa | 4 |
Stuart L. Marcus | 3 |
Michael Wootton | 2 |
Victor Neel | 2 |
Anna Mandinova | 2 |
Anna Houlihan | 1 |
Vincent Sai | 1 |
- Stock Market
- Insiders
- Mark de Souza
- Company connections